method, spheroids of cells are created from a donor – usually the patient – and then constructed by the Regenova, which is effectively a computerized, cell-growing robot. It produces a living scaffold-free cell structure that can be sutured – a world first – and implanted into the body with minimal fear of rejection.
“A surgeon begged me to help him and produce a heart simulator,” Takeda recalls. “Open-heart surgery is not the kind of operation you want to repeat, especially with young children, and the doctor said it was vital to have a simulated heart to avoid loss of life.” Takeda Masatoshi, CEO of crossMedical, Inc., responded to a plea from a doctor to produce a true simulated heart for clinical use.Surgery should be made easier with the introduction of Mitaka Kohki’s MIPS, a body projection mapping system that the company has produced in partnership with Kyoto University and Panasonic i-PRO Sensing Solutions.
For Mitaka Kohki, MIPS was a step up from their other products, which include telescopes and microscopes. “We had to be really sure in the development of this product because it involves the life of patients,” says Director Nakamura Katsuyuki. “Our other products are mainly used for observation, but MIPS assists surgeons directly in operations.
JapanGov This gonna be expensive...
JapanGov ichiban